Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros










Intervalo de año de publicación
1.
Trop Biomed ; 39(3): 421-427, 2022 09 01.
Artículo en Inglés | MEDLINE | ID: mdl-36214439

RESUMEN

The early molecular identification of strains of Plasmodium vivax that have a worse prognosis is important to stratify the risk of complications and choice of conduct made by medical teams. Thus, the aim of the present study was to associate the presence of polymorphisms in the pvmdr-1 and pvcrt-o resistance genes of P. vivax in patients with better or worse prognosis. This cross-sectional epidemiological study was conducted based on data obtained from the records of 120 patients diagnosed with malaria in the Brazilian Amazon. The T958M and F1076L mutations of the pvmdr-1 gene had a frequency of 3.3 and 4.2%, respectively, and primo-infected patients had a 17 times greater chance of being infected with protozoa with the T958M mutation compared to patients with previous episodes. Regarding pvcrt-o, the C393T and T786C polymorphisms had a frequency of 14.2 and 3.3%, respectively, and self-declared white patients had a 3.1 times greater chance of being infected with protozoa with the C393T polymorphism. In addition, patients with this pvcrt-o polymorphism had lower concentrations of C-reactive protein, indicating a better prognosis. These data present clues of genetic indicators useful for assessing the virulence of the parasite and the prognosis of patients with vivax malaria.


Asunto(s)
Antimaláricos , Malaria Vivax , Antimaláricos/farmacología , Proteína C-Reactiva , Cloroquina/uso terapéutico , Estudios Transversales , Resistencia a Medicamentos/genética , Humanos , Malaria Vivax/tratamiento farmacológico , Plasmodium vivax/genética , Plasmodium vivax/metabolismo , Pronóstico , Proteínas Protozoarias/genética , Proteínas Protozoarias/metabolismo
2.
Tropical Biomedicine ; : 421-427, 2022.
Artículo en Inglés | WPRIM (Pacífico Occidental) | ID: wpr-960358

RESUMEN

@#The early molecular identification of strains of Plasmodium vivax that have a worse prognosis is important to stratify the risk of complications and choice of conduct made by medical teams. Thus, the aim of the present study was to associate the presence of polymorphisms in the pvmdr-1 and pvcrt-o resistance genes of P. vivax in patients with better or worse prognosis. This cross-sectional epidemiological study was conducted based on data obtained from the records of 120 patients diagnosed with malaria in the Brazilian Amazon. The T958M and F1076L mutations of the pvmdr-1 gene had a frequency of 3.3 and 4.2%, respectively, and primo-infected patients had a 17 times greater chance of being infected with protozoa with the T958M mutation compared to patients with previous episodes. Regarding pvcrt-o, the C393T and T786C polymorphisms had a frequency of 14.2 and 3.3%, respectively, and self-declared white patients had a 3.1 times greater chance of being infected with protozoa with the C393T polymorphism. In addition, patients with this pvcrt-o polymorphism had lower concentrations of C-reactive protein, indicating a better prognosis. These data present clues of genetic indicators useful for assessing the virulence of the parasite and the prognosis of patients with vivax malaria.

3.
Braz J Med Biol Res ; 46(2): 164-70, 2013 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-23558932

RESUMEN

Myosin Va functions as a processive, actin-based motor molecule highly enriched in the nervous system, which transports and/or tethers organelles, vesicles, and mRNA and protein translation machinery. Mutation of myosin Va leads to Griscelli disease that is associated with severe neurological deficits and a short life span. Despite playing a critical role in development, the expression of myosin Va in the central nervous system throughout the human life span has not been reported. To address this issue, the cerebellar expression of myosin Va from newborns to elderly humans was studied by immunohistochemistry using an affinity-purified anti-myosin Va antibody. Myosin Va was expressed at all ages from the 10th postnatal day to the 98 th year of life, in molecular, Purkinje and granular cerebellar layers. Cerebellar myosin Va expression did not differ essentially in localization or intensity from childhood to old age, except during the postnatal developmental period. Structures resembling granules and climbing fibers in Purkinje cells were deeply stained. In dentate neurons, long processes were deeply stained by anti-myosin Va, as were punctate nuclear structures. During the first postnatal year, myosin Va was differentially expressed in the external granular layer (EGL). In the EGL, proliferating prospective granule cells were not stained by anti-myosin Va antibody. In contrast, premigratory granule cells in the EGL stained moderately. Granule cells exhibiting a migratory profile in the molecular layer were also moderately stained. In conclusion, neuronal myosin Va is developmentally regulated, and appears to be required for cerebellar function from early postnatal life to senescence.


Asunto(s)
Cerebelo/metabolismo , Miosina Tipo V/metabolismo , Adolescente , Adulto , Factores de Edad , Anciano , Anciano de 80 o más Años , Cadáver , Niño , Preescolar , Electroforesis en Gel de Agar , Femenino , Humanos , Immunoblotting , Inmunohistoquímica , Lactante , Recién Nacido , Masculino , Adulto Joven
4.
Braz. j. med. biol. res ; 46(2): 164-170, 01/fev. 2013. tab, graf
Artículo en Inglés | LILACS | ID: lil-668777

RESUMEN

Myosin Va functions as a processive, actin-based motor molecule highly enriched in the nervous system, which transports and/or tethers organelles, vesicles, and mRNA and protein translation machinery. Mutation of myosin Va leads to Griscelli disease that is associated with severe neurological deficits and a short life span. Despite playing a critical role in development, the expression of myosin Va in the central nervous system throughout the human life span has not been reported. To address this issue, the cerebellar expression of myosin Va from newborns to elderly humans was studied by immunohistochemistry using an affinity-purified anti-myosin Va antibody. Myosin Va was expressed at all ages from the 10th postnatal day to the 98th year of life, in molecular, Purkinje and granular cerebellar layers. Cerebellar myosin Va expression did not differ essentially in localization or intensity from childhood to old age, except during the postnatal developmental period. Structures resembling granules and climbing fibers in Purkinje cells were deeply stained. In dentate neurons, long processes were deeply stained by anti-myosin Va, as were punctate nuclear structures. During the first postnatal year, myosin Va was differentially expressed in the external granular layer (EGL). In the EGL, proliferating prospective granule cells were not stained by anti-myosin Va antibody. In contrast, premigratory granule cells in the EGL stained moderately. Granule cells exhibiting a migratory profile in the molecular layer were also moderately stained. In conclusion, neuronal myosin Va is developmentally regulated, and appears to be required for cerebellar function from early postnatal life to senescence.


Asunto(s)
Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Niño , Preescolar , Femenino , Humanos , Lactante , Recién Nacido , Masculino , Adulto Joven , Cerebelo/metabolismo , Miosina Tipo V/metabolismo , Factores de Edad , Cadáver , Electroforesis en Gel de Agar , Immunoblotting , Inmunohistoquímica
5.
Caries Res ; 46(4): 339-45, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-22614073

RESUMEN

To evaluate whether protein changes in extracellular matrix of dental biofilm are a unique property of sucrose, this in situ study was conducted using as active control glucose and fructose, the sucrose monosaccharide constituents. Proteins were analyzed by two-dimensional electrophoresis followed by LC-MS/MS after trypsin digestion. Absence or lower abundance of calcium-binding proteins and higher abundance of prolactin-induced proteins were found in biofilm formed in the presence of sucrose or its monosaccharide constituents compared with water, the negative control group. The data suggest that besides sucrose, other dietary carbohydrates may also provoke a change in the protein profile of extracellular matrix of dental biofilm formed.


Asunto(s)
Biopelículas , Carbohidratos de la Dieta/farmacología , Proteínas de la Matriz Extracelular/análisis , Fructosa/farmacología , Glucosa/farmacología , Proteoma/análisis , Adulto , Biopelículas/efectos de los fármacos , Proteínas de Unión al Calcio/análisis , Calgranulina B/análisis , Proteínas Portadoras/análisis , Cromatografía Liquida , Estudios Cruzados , Electroforesis en Gel Bidimensional , Proteínas de la Matriz Extracelular/efectos de los fármacos , Glicoproteínas/análisis , Humanos , Focalización Isoeléctrica , Proteínas de Transporte de Membrana , Proteínas y Péptidos Salivales/análisis , Sacarosa/farmacología , Espectrometría de Masas en Tándem , Tripsina , Agua
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...